Sitka Biopharma: CDRD Invests in Sitka Biopharma to Advance Bladder Cancer Treatment to Clinical Trial
CDRD, Canada's national life sciences venture, is pleased to announce an increased commitment to Sitka Biopharma with a $1.2M investment.
Read full article »
Sitka Biopharma focuses on developing a nanoparticle platform to increase drug absorption of difficult-to-penetrate tissues in cancer treatments.
Read more